FilingReader Intelligence
China Resources Pharmaceutical Group announces key subsidiary results
April 28, 2025 at 05:21 PM UTC•By FilingReader AI
China Resources Pharmaceutical Group Limited (HKEX:3320) has announced the unaudited financial results of its key subsidiaries for the three months ended March 31, 2025. KPC Pharmaceuticals, Tasly Pharmaceuticals, and CR Sanjiu each released their respective quarterly reports on April 28, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:3320•Hong Kong Exchange
News Alerts
Get instant email alerts when China Resources Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime